REVIEW OF SAFETY AND TOLERANCE OF OMALIZUMAB
<em>The review of safety of monoclonal anti-ige-antibodies (xolair) - a new medication for the treatment of severe allergic bronchial asthma is presented. Local and system adverse events, originating after injection of medicament in clinical studies and following administration in patients are...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Libro |
| Publicado: |
"Paediatrician" Publishers LLC,
2008-01-01T00:00:00Z.
|
| Materias: | |
| Acceso en línea: | Connect to this object online. |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!